-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NCzCoefMENvAHy+OWlUvYqZ6RZ8XN0g2xqvzJca9Y7Zrtgc0kzS6tcyBN3X57zC4 ZTwfe0EOIiD9lKneeLpGPA== /in/edgar/work/20000605/0000758722-00-000052/0000758722-00-000052.txt : 20000919 0000758722-00-000052.hdr.sgml : 20000919 ACCESSION NUMBER: 0000758722-00-000052 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20000525 FILED AS OF DATE: 20000605 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PARACELSUS HEALTHCARE CORP CENTRAL INDEX KEY: 0000758722 STANDARD INDUSTRIAL CLASSIFICATION: [8062 ] IRS NUMBER: 953565943 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: SEC FILE NUMBER: 001-12055 FILM NUMBER: 649141 BUSINESS ADDRESS: STREET 1: 515 W GREENS RD STREET 2: STE 800 CITY: HOUSTON STATE: TX ZIP: 77067 BUSINESS PHONE: 2817745100 MAIL ADDRESS: STREET 1: 515 W GREENS RD STREET 2: STE 800 CITY: HOUSTON STATE: TX ZIP: 77067 COMPANY DATA: COMPANY CONFORMED NAME: HADDOX MELISSA CENTRAL INDEX KEY: 0001115939 STANDARD INDUSTRIAL CLASSIFICATION: [ ]OFFICER IRS NUMBER: 953565943 FILING VALUES: FORM TYPE: 3 BUSINESS ADDRESS: STREET 1: 515 WEST GREENS ROAD STREET 2: SUITE 500 CITY: HOUSTON STATE: TX ZIP: 77067 BUSINESS PHONE: 2817745100 MAIL ADDRESS: STREET 1: 515 W. GREENS ROAD STREET 2: SUITE 500 CITY: HOUSTON STATE: TX ZIP: 77067 3 1 0001.txt FORM 3 - 05/25/00 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 1. Name and Address of Reporting Person Haddox, Melissa R. Paracelsus Healthcare Corporation 515 W. Greens Road Suite 500 Houston, Tx 77067 USA 2. Date of Event Requiring Statement (Month/Day/Year) 05/25/00 3. IRS or Social Security Number of Reporting Person (Voluntary) 4. Issuer Name and Ticker or Trading Symbol Paracelsus Healthcare Corporation PLS 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) ( ) Director ( ) 10% Owner (X) Officer (give title below) ( ) Other (specify below) Vice President - Government Programs 6. If Amendment, Date of Original (Month/Day/Year) 7. Individual or Joint/Group Filing (Check Applicable Line) (X) Form filed by One Reporting Person ( ) Form filed by More than One Reporting Person
___________________________________________________________________________________________________________________________________ Table I -- Non-Derivative Securities Beneficially Owned | ___________________________________________________________________________________________________________________________________| 1. Title of Security |2. Amount of |3. Ownership |4. Nature of Indirect | | Securities | Form: | Beneficial Ownership | | Beneficially | Direct(D) or | | | Owned | Indirect(I) | | ___________________________________________________________________________________________________________________________________| Common stock |2,100 |D | | - -----------------------------------------------------------------------------------------------------------------------------------| ___________________________________________________________________________________________________________________________________| ___________________________________________________________________________________________________________________________________ Table II -- Derivative Securitites Beneficially Owned | ___________________________________________________________________________________________________________________________________| 1.Title of Derivative |2.Date Exer- |3.Title and Amount | |4. Conver-|5. Owner- |6. Nature of Indirect | Security | cisable and | of Underlying | |sion or |ship | Beneficial Ownership | | Expiration | Securities | |exercise |Form of | | | Date(Month/ |-----------------------|---------|price of |Deriv- | | | Day/Year) | |Amount |deri- |ative | | | Date | Expira- | |or |vative |Security: | | | Exer- | tion | Title |Number of|Security |Direct(D) or | | | cisable | Date | |Shares | |Indirect(I) | | ___________________________________________________________________________________________________________________________________| Options to purchase comm|(a) |07/10/07 |Common stock |30,000 |$5.19 |D | | on stock | | | | | | | | - -----------------------------------------------------------------------------------------------------------------------------------| Options to purchase comm|(b) |04/01/09 |Common stock |30,000 |$2.20 |D | | on stock | | | | | | | | - -----------------------------------------------------------------------------------------------------------------------------------| ___________________________________________________________________________________________________________________________________|
Explanation of Responses: (a) Options exercisable proratably on a monthly basis over a four-year period commencing July 7, 1997. (b) Options exercisable as follows: 25% on April 1, 1999; 25% on April 1, 2000; 16-2/3% on April 1, 2001; 16-2/3% on April 1, 2002 and 16-2/3% on March 31, 2003. SIGNATURE OF REPORTING PERSON Mai-Phuong N. Garland, Attorney-in-Fact DATE 06/05/00 -----END PRIVACY-ENHANCED MESSAGE-----